The Race for Ozempic Alternatives: Unlocking the Future of Weight Loss Medication
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Stage III Cutaneous Melanoma AJCC v7
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00041
Aldesleukin
1
Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB08912
Dabrafenib
1
Active Not Recruiting
1
DB08912
Dabrafenib
1
Terminated
1
DB01073
Fludarabine
1
Recruiting
1
DB01611
Hydroxychloroquine
1
Active Not Recruiting
1
DB09053
Ibrutinib
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Terminated
2
DB17107
Lifileucel
1
Recruiting
1
DB16828
MK-2206
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Terminated
2
DB06306
Onalespib
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Active Not Recruiting
1
DB00740
Riluzole
1
Active Not Recruiting
1
DB06176
Romidepsin
1
Active Not Recruiting
1
DB00398
Sorafenib
1
Active Not Recruiting
1
DB08911
Trametinib
1
Active Not Recruiting
1
DB08911
Trametinib
1
Terminated
1
DB00041
Aldesleukin
1 / 2
Completed
1
DB00531
Cyclophosphamide
1 / 2
Completed
1
DB01073
Fludarabine
1 / 2
Completed
1
DB05996
Glembatumumab vedotin
1 / 2
Withdrawn
1
DB06186
Ipilimumab
1 / 2
Completed
1
DB06186
Ipilimumab
1 / 2
Withdrawn
1
DB17107
Lifileucel
1 / 2
Completed
1
DB09035
Nivolumab
1 / 2
Completed
1
DB09035
Nivolumab
1 / 2
Withdrawn
1
DB09037
Pembrolizumab
1 / 2
Active Not Recruiting
1
DB08885
Aflibercept
2
Completed
1
DB00041
Aldesleukin
2
Completed
2
DB11967
Binimetinib
2
Active Not Recruiting
1
DB11059
Carboxymethylcellulose
2
Completed
1
DB00531
Cyclophosphamide
2
Completed
1
DB08912
Dabrafenib
2
Active Not Recruiting
2
DB11718
Encorafenib
2
Active Not Recruiting
1
DB01073
Fludarabine
2
Completed
1
DB17293
Hiltonol
2
Completed
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB00123
Lysine
2
Completed
1
DB15994
Methane
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB15185
Rasdegafusp alfa
2
Completed
1
DB00020
Sargramostim
2
Active Not Recruiting
1
DB13896
Talimogene laherparepvec
2
Active Not Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
2
DB06186
Ipilimumab
2 / 3
Recruiting
1
DB09035
Nivolumab
2 / 3
Recruiting
1
DB00020
Sargramostim
2 / 3
Recruiting
1